Find your next paid study

Solu Therapeutics, IncNCT06950034

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome (TTTS)

The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with…

Twin to Twin Transfusion as Antepartum ConditionMonochorionic Diamniotic Placenta

Seattle Children's HospitalNCT05008744

~$10 – $750

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdult T-Cell Leukemia/Lymphoma+14 more

A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning

This phase II clinical trial evaluates whether a modified modality of conditioning reduces treatment-related mortality (TRM) in patients who undergo a hematopo…

Thomas Jefferson UniversityNCT05031897

~$10 – $6,250

Buckeye Surveillance, Contact, and Research for Multiple Myeloma and Amyloidosis

The investigators are researching patients with diseases of their plasma cells in order to improve their quality and length of life. The investigators have cre…

Plasma Cell DyscrasiasMonoclonal Gammopathy of Undetermined SignificanceAL Amyloidosis+1 more

Ohio State University Comprehensive Cancer CenterNCT01408225

~$10 – $750

Sleep Apnea in Patients With MGUS and MM

This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and …

Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance

Michael TomassonNCT04114084

~$10 – $1,125

Hematologic MalignancyAcute LeukemiaRemission+21 more

Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies

This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion (TCR α/β TCD) peripheral blood stem cell (PBSC) transplantation for c…

Masonic Cancer Center, University of Minnesota

~$10 – $6,250

Myelodysplastic SyndromesAcute Myeloid LeukemiaMyelodysplastic Syndrome/Neoplasm+1 more

A Multi-phase, Pharmacokinetics, Safety, and Efficacy Study of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy in Subjects With Myeloid Neoplasm or in Combination With Venetoclax in Subjects With AML (AZTOUND Study)

Study ASTX030-01 is a multi-phase study comprising of Phases 1-3 Monotherapy arms, and Phase 1 and Phase 2 Combination Therapy arms. Phase 1 Monotherapy consis…

Taiho Oncology, Inc.NCT04256317

Phase 1

Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)

The purpose of this Phase 1, first in human open-label study is to assess the safety and tolerability of TRX-103 in patients with hematological malignancies un…

Hematologic MalignancyGvHDGVHD,Acute+8 more

Gastroesophageal-junction CancerMonoclonal AntibodyGastric Cancer+1 more

Tr1X, Inc.NCT06462365

Phase 3

A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination With Trastuzumab and Chemotherapy (XELOX) Versus Trastuzumab and Chemotherapy (XELOX) With or Without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer

This is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with t…

Shanghai Henlius BiotechNCT06532006

Genotype-Phenotype Correlation in Patients With Chromosome 9 P Minus Syndrome

Patients with deletion of chromosome 9 P are rare (\~200 in the medical literature) and have a diverse set of phenotypic characteristics. We propose using stat…

Chromosome 9P Deletion Syndrome9p Minus SyndromeAlfi Syndrome+2 more

Washington University School of MedicineNCT04586400

~$10 – $750

Monomorphic B-Cell Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder

Phase II Study to Assess the Efficacy of Combined Tafasitamab and Rituximab in Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

This phase II trial tests how well tafasitamab and rituximab work for front-line treatment of patients with post-transplant lymphoproliferative disorder. Post-…

Timothy VoorheesNCT05786040

~$10 – $7,500

Phase 1

A Phase 1/2a Open-label, Multicenter Dose Finding Study to Evaluate the Safety and Anti-tumor Activity of Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

This is a Phase 1/2a, open-label, non-randomized, multi-dose study of mirdametinib monotherapy in adults with NF1 and cNF. In both Phases of the study, partic…

NF1Cutaneous NeurofibromaMonotherapy